• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原花青素作为抗 SARS-CoV-2 治疗剂的潜在作用:文本挖掘、分子对接和分子动力学模拟方法。

The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach.

机构信息

Computational Biology Division, DRDO Center for Life Sciences, Bharathiar University Campus, Coimbatore, Tamil Nadu, India.

Center for Condensed Matter Theory, Department of Physics, Indian Institute of Science, Bangalore, Karnataka, India.

出版信息

J Biomol Struct Dyn. 2022 Feb;40(3):1230-1245. doi: 10.1080/07391102.2020.1823887. Epub 2020 Sep 22.

DOI:10.1080/07391102.2020.1823887
PMID:32960159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7544928/
Abstract

A novel coronavirus (SARS-CoV-2) has caused a major outbreak in human all over the world. There are several proteins interplay during the entry and replication of this virus in human. Here, we have used text mining and named entity recognition method to identify co-occurrence of the important COVID 19 genes/proteins in the interaction network based on the frequency of the interaction. Network analysis revealed a set of genes/proteins, highly dense genes/protein clusters and sub-networks of Angiotensin-converting enzyme 2 (ACE2), Helicase, spike (S) protein (trimeric), membrane (M) protein, envelop (E) protein, and the nucleocapsid (N) protein. The isolated proteins are screened against procyanidin-a flavonoid from plants using molecular docking. Further, molecular dynamics simulation of critical proteins such as ACE2, Mpro and spike proteins are performed to elucidate the inhibition mechanism. The strong network of hydrogen bonds and hydrophobic interactions along with van der Waals interactions inhibit receptors, which are essential to the entry and replication of the SARS-CoV-2. The binding energy which largely arises from van der Waals interactions is calculated (ACE2=-50.21 ± 6.3, Mpro=-89.50 ± 6.32 and spike=-23.06 ± 4.39) through molecular mechanics Poisson-Boltzmann surface area also confirm the affinity of procyanidin towards the critical receptors. Communicated by Ramaswamy H. Sarma.

摘要

一种新型冠状病毒(SARS-CoV-2)在全球范围内引发了重大疫情。在该病毒进入人体并在人体内复制的过程中,有几种蛋白质相互作用。在这里,我们使用文本挖掘和命名实体识别方法,根据相互作用的频率,在基于相互作用的网络中识别出重要的 COVID-19 基因/蛋白质的共现。网络分析揭示了一组基因/蛋白质、高度密集的基因/蛋白质簇以及血管紧张素转化酶 2(ACE2)、解旋酶、刺突(S)蛋白(三聚体)、膜(M)蛋白、包膜(E)蛋白和核衣壳(N)蛋白的子网络。使用分子对接从植物中原位筛选出与原花青素 A 结合的分离蛋白。进一步对 ACE2、Mpro 和刺突蛋白等关键蛋白进行分子动力学模拟,以阐明抑制机制。氢键和疏水相互作用以及范德华相互作用的强网络抑制了受体,这对于 SARS-CoV-2 的进入和复制是必不可少的。通过分子力学泊松-玻尔兹曼表面积计算(ACE2=-50.21 ± 6.3,Mpro=-89.50 ± 6.32 和 spike=-23.06 ± 4.39)也证实了原花青素对关键受体的亲和力。由 Ramaswamy H. Sarma 传达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b47/7544928/890c95dc6c54/TBSD_A_1823887_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b47/7544928/890c95dc6c54/TBSD_A_1823887_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b47/7544928/890c95dc6c54/TBSD_A_1823887_UF0001_C.jpg

相似文献

1
The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach.原花青素作为抗 SARS-CoV-2 治疗剂的潜在作用:文本挖掘、分子对接和分子动力学模拟方法。
J Biomol Struct Dyn. 2022 Feb;40(3):1230-1245. doi: 10.1080/07391102.2020.1823887. Epub 2020 Sep 22.
2
Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.针对血管紧张素转化酶 2(ACE2)受体的不同化合物可能含有 SARS-CoV-2 的感染力:一项计算机研究。
J Mol Model. 2022 Mar 5;28(4):82. doi: 10.1007/s00894-022-05059-1.
3
Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2.通过针对刺突 RBD 和人 ACE2 之间的界面区域,鉴定潜在的 SARS-CoV-2 进入抑制剂。
J Infect Public Health. 2021 Feb;14(2):227-237. doi: 10.1016/j.jiph.2020.12.014. Epub 2020 Dec 21.
4
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.截短的人血管紧张素转换酶2;一种潜在的严重急性呼吸综合征冠状病毒2刺突糖蛋白抑制剂和有效的2019冠状病毒病治疗剂。
J Biomol Struct Dyn. 2021 Jul;39(10):3605-3614. doi: 10.1080/07391102.2020.1768150. Epub 2020 May 20.
5
Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an study for drug development.用天然植物化学物质靶向 COVID-19 的 SARS-CoV-2 刺突蛋白:一项药物研发研究。
J Biomol Struct Dyn. 2021 Oct;39(16):6306-6316. doi: 10.1080/07391102.2020.1796811. Epub 2020 Jul 22.
6
screening of natural compounds to inhibit interaction of human ACE2 receptor and spike protein of SARS-CoV-2 for the prevention of COVID-19.筛选天然化合物以抑制人类ACE2受体与SARS-CoV-2刺突蛋白的相互作用,用于预防新型冠状病毒肺炎。
J Biomol Struct Dyn. 2023 Feb;41(2):646-658. doi: 10.1080/07391102.2021.2010599. Epub 2021 Dec 2.
7
Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.分子对接、分子动力学模拟和反应性研究,以 ACE2 为靶点的已批准药物库针对 ACE2 和 SARS-CoV-2 与 ACE2 结合的研究。
J Biomol Struct Dyn. 2021 Nov;39(18):7246-7262. doi: 10.1080/07391102.2020.1803967. Epub 2020 Aug 5.
8
Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.突变对人 SARS-CoV-2 受体结合域与宿主细胞受体 ACE2 结构、功能和动力学的影响:分子动力学模拟研究。
J Biomol Struct Dyn. 2021 Nov;39(18):7231-7245. doi: 10.1080/07391102.2020.1802348. Epub 2020 Aug 7.
9
Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.揭示 SARS-CoV-2 刺突蛋白变体对人类受体的影响:一种分子动力学对接和模拟方法。
J Infect Public Health. 2023 Oct;16(10):1544-1555. doi: 10.1016/j.jiph.2023.07.011. Epub 2023 Jul 24.
10
Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.病毒-宿主互作组学途径富集分析及针对刺突糖蛋白受体结合域-人血管紧张素转化酶 2 界面的新型化合物的优先级排序,以对抗 SARS-CoV-2。
J Biomol Struct Dyn. 2022 Apr;40(6):2701-2714. doi: 10.1080/07391102.2020.1841681. Epub 2020 Nov 4.

引用本文的文献

1
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal.小分子药物治疗长新冠相关血管损伤和异常血栓形成:基于专利的评估。
Viruses. 2024 Mar 14;16(3):450. doi: 10.3390/v16030450.
2
SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors.考虑宿主因素的SARS-CoV-2在各器官中的细胞嗜性机制。
Heliyon. 2024 Feb 20;10(4):e26577. doi: 10.1016/j.heliyon.2024.e26577. eCollection 2024 Feb 29.
3
A study on the effect of natural products against the transmission of B.1.1.529 Omicron.

本文引用的文献

1
Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).逆转录重组酶扩增检测法快速检测 2019 新型冠状病毒(SARS-CoV-2)。
Anal Chem. 2020 Jul 21;92(14):9699-9705. doi: 10.1021/acs.analchem.0c01032. Epub 2020 Jul 10.
2
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.新型冠状病毒木瓜样蛋白酶的去泛素酶和去ISG15酶活性的表征及非共价抑制作用
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109. doi: 10.1021/acsinfecdis.0c00168. Epub 2020 Jun 4.
3
The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor.
一项关于天然产物对 B.1.1.529 奥密克戎传播抑制作用的研究。
Virol J. 2023 Aug 25;20(1):191. doi: 10.1186/s12985-023-02160-6.
4
Interactions between carbon nanotubes and external structures of SARS-CoV-2 using molecular docking and molecular dynamics.利用分子对接和分子动力学研究碳纳米管与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)外部结构之间的相互作用。
J Mol Struct. 2023 Aug 15;1286:135604. doi: 10.1016/j.molstruc.2023.135604. Epub 2023 Apr 18.
5
Inhibitory effects and mechanisms of proanthocyanidins against enterovirus 71 infection.原花青素抗肠道病毒 71 感染的抑制作用及机制。
Virus Res. 2023 May;329:199098. doi: 10.1016/j.virusres.2023.199098. Epub 2023 Mar 22.
6
Natural Inhibitors Targeting the Localization of Lipoprotein System in .靶向脂蛋白系统定位的天然抑制剂。
Int J Mol Sci. 2022 Nov 18;23(22):14352. doi: 10.3390/ijms232214352.
7
Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review.生物活性化合物作为针对 COVID-19 的潜在血管紧张素转化酶 II 抑制剂:范围综述。
Inflamm Res. 2022 Dec;71(12):1489-1500. doi: 10.1007/s00011-022-01642-7. Epub 2022 Oct 28.
8
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases.贝壳杉素,一种天然双黄酮,通过靶向 SARS-CoV-2 的蛋白酶来抑制其复制。
Int J Biol Macromol. 2022 Dec 1;222(Pt A):1015-1026. doi: 10.1016/j.ijbiomac.2022.09.204. Epub 2022 Sep 29.
9
Phenolic Fraction from Peanut ( L.) By-product: Innovative Extraction Techniques and New Encapsulation Trends for Its Valorization.花生(L.)副产品中的酚类成分:创新提取技术及其增值的新型包封趋势
Food Bioproc Tech. 2023;16(4):726-748. doi: 10.1007/s11947-022-02901-5. Epub 2022 Sep 15.
10
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.基于方法的 SARS-CoV-2 分子建模、模拟和预测综述。
Chem Rev. 2022 Jul 13;122(13):11287-11368. doi: 10.1021/acs.chemrev.1c00965. Epub 2022 May 20.
SARS-CoV-2 对人类 ACE2 受体的作用具有独特的策略。
Viruses. 2020 Apr 30;12(5):497. doi: 10.3390/v12050497.
4
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment.新型 2019 年冠状病毒结构、作用机制、抗病毒药物前景及其治疗排除。
J Biomol Struct Dyn. 2021 Jun;39(9):3409-3418. doi: 10.1080/07391102.2020.1758788. Epub 2020 Apr 30.
5
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
6
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19.洛匹那韦、奥司他韦和利托那韦与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶结合用于治疗2019冠状病毒病(COVID-19)的药物重新利用和协同作用的计算研究
J Biomol Struct Dyn. 2021 Apr;39(7):2673-2678. doi: 10.1080/07391102.2020.1752802. Epub 2020 Apr 16.
7
approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel.检测人类严重急性呼吸系统综合征冠状病毒包膜蛋白离子通道抑制剂的方法。
J Biomol Struct Dyn. 2021 Apr;39(7):2617-2627. doi: 10.1080/07391102.2020.1751300. Epub 2020 Apr 15.
8
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.鉴定 2019 新型冠状病毒的受体结合域(RBD):作为病毒附着抑制剂和疫苗开发 RBD 蛋白的意义。
Cell Mol Immunol. 2020 Jun;17(6):613-620. doi: 10.1038/s41423-020-0400-4. Epub 2020 Mar 19.
9
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒(2019-nCoV/SARS-CoV-2)药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
10
Procyanidin C1 Inhibits Melanoma Cell Growth by Activating 67-kDa Laminin Receptor Signaling.原花青素 C1 通过激活 67 kDa 层粘连蛋白受体信号抑制黑素瘤细胞生长。
Mol Nutr Food Res. 2020 Apr;64(7):e1900986. doi: 10.1002/mnfr.201900986. Epub 2020 Mar 6.